Gait patterns in COPD: The Rotterdam study

European Respiratory Journal

Volumn 46, Issue 1, 2015, Pages 88-95

  Lahousse, Lies ^a,b   Verlinden, Vincentius J A ^b   Van Der Geest, Jos N ^b   Joos, Guy F ^a   Hofman, Albert ^b,c   Stricker, Bruno H C ^b,c,d   Brusselle, Guy G ^a,b   Ikram, M Arfan ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Netherlands Center for Healthy Ageing   (Netherlands)

^d Inspectorate of Healthcare   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY EQUILIBRIUM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DOUBLE SUPPORT TIME; FALLING; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; STRIDE LENGTH; STRIDE LENGTH VARIABILITY; STRIDE TIME; STRIDE WIDTH; WALKING SPEED; BIOMECHANICS; COMPLICATION; DYSPNEA; FORCED EXPIRATORY VOLUME; GAIT; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; SMOKING; SPIROMETRY; VITAL CAPACITY; WALKING;

AGED; BIOMECHANICAL PHENOMENA; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GAIT; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; VITAL CAPACITY; WALKING;

EID: 84937468338     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00213214     Document Type: Article

References (36)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
3. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008; 121: 789-796.
4. Beauchamp MK, Sibley KM, Lakhani B, et al. Impairments in systems underlying control of balance in COPD. Chest 2012; 141: 1496-1503.
5. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010; 35: 913-922.
6. Snijders AH, van de Warrenburg BP, Giladi N, et al. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007; 6: 63-74.
7. Gill TM, Allore HG, Gahbauer EA, et al. Change in disability after hospitalization or restricted activity in older persons. JAMA 2010; 304: 1919-1928.
8. Roig M, Eng JJ, Road JD, et al. Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respir Med 2009; 103: 1257-1269.
9. Kannus P, Sievanen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005; 366: 1885-1893.
10. Jorstad EC, Hauer K, Becker C, et al. Measuring the psychological outcomes of falling: a systematic review. J Am Geriatr Soc 2005; 53: 501-510.
11. Bridenbaugh SA, Kressig RW. Laboratory review: the role of gait analysis in seniors' mobility and fall prevention. Gerontology 2011; 57: 256-264.
12. Mignardot JB, Deschamps T, Barrey E, et al. Gait disturbances as specific predictive markers of the first fall onset in elderly people: a two-year prospective observational study. Front Aging Neurosci 2014; 6: 22.
13. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009; 13: 881-889.
14. Cesari M. Role of gait speed in the assessment of older patients. JAMA 2011; 305: 93-94.
15. Verghese J, Holtzer R, Lipton RB, et al. Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci 2009; 64: 896-901.
16. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011; 305: 50-58.
17. Verlinden VJ, van der Geest JN, Hofman A, et al. Cognition and gait show a distinct pattern of association in the general population. Alzheimers Dement 2014; 10: 328-335.
18. Watson NL, Sutton-Tyrrell K, Youk AO, et al. Arterial stiffness and gait speed in older adults with and without peripheral arterial disease. Am J Hypertens 2011; 24: 90-95.
19. Verlinden VJ, van der Geest JN, Hoogendam YY, et al. Gait patterns in a community-dwelling population aged 50 years and older. Gait Posture 2013; 37: 500-505.
20. Callisaya ML, Blizzard L, Schmidt MD, et al. A population-based study of sensorimotor factors affecting gait in older people. Age Ageing 2009; 38: 290-295.
21. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011; 26: 657-686.
22. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
23. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
24. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
25. Lahousse L, van den Bouwhuijsen Q, Loth DW, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med 2013; 187: 58-64.
26. Brach JS, Perera S, Studenski S, et al. The reliability and validity of measures of gait variability in community-dwelling older adults. Arch Phys Med Rehabil 2008; 89: 2293-2296.
27. Karpman C, Depew ZS, LeBrasseur NK, et al. Determinants of Gait Speed in COPD. Chest 2014; 146: 104-110.
28. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
29. Lahousse L, Vernooij MW, Darweesh SK, et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am J Respir Crit Care Med 2013; 188: 783-788.
30. Lehouck A, Boonen S, Decramer M, et al. COPD, bone metabolism, and osteoporosis. Chest 2011; 139: 648-657.
31. Campos-Obando N, Castano-Betancourt MC, Oei L, et al. Bone mineral density and chronic lung disease mortality: the Rotterdam study. J Clin Endocrinol Metab 2014; 99: 1834-1842.
32. Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: e15-e62.
33. Hausdorff JM, Edelberg HK, Mitchell SL, et al. Increased gait unsteadiness in community-dwelling elderly fallers. Arch Phys Med Rehabil 1997; 78: 278-283.
34. Hayden R, Clair AA, Johnson G, et al. The effect of rhythmic auditory stimulation (RAS) on physical therapy outcomes for patients in gait training following stroke: a feasibility study. Int J Neurosci 2009; 119: 2183-2195.
35. Yentes JM, Sayles H, Meza J, et al. Walking abnormalities are associated with COPD: an investigation of the NHANES III dataset. Respir Med 2011; 105: 80-87.
36. Roberts MH, Mapel DW, Hartry A, et al. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc 2013; 10: 290-298.